РОЛЬ МЕТИЛИРОВАНИЯ ДНК В НАРУШЕНИИ КОСТНОГО МЕТАБОЛИЗМАYalaev, B.I.,
Tyurin, A.V.,
Mirgalieva, R.Y.,
Khusainova, R.I.,
ЯЛАЕВ Б.И.,
ТЮРИН А.В.,
МИРГАЛИЕВА Р.Я.,
ХУСАИНОВА Р.И. (2019) pathogenetic links in its structure. Decreases in bone mass and matrix mineralization as well as
changes KURKINA, M.V.,
MIHAYLOVA, S.V.,
BAIDAKOVA, G.V.,
SAIFULLINA, E.V.,
KOROSTELEV, S.A.,
PYANKOV, D.V.,
KANIVETS, I.V.,
YUNIN, M.A.,
PECHATNIKOVA, N.L.,
ZAKHAROVA, E.YU (2020) presented typical GA1 biochemical
changes in the biological fluids, except one patient with the homozygous
LIU, Z.,
ZHANG, R.,
CHEN, X.,
YAO, P.,
YAN, T.,
LIU, W.,
YAO, J.,
ZHAO, S.,
SOKHATSKII, A.,
GAREEV, I. (2019) for differentially expressed genes (DEGs) in ICH, with a fold
change (FC) value of (|log2FC|) > 2 and a P-value of <0
LV, L.,
ZHANG, L.,
LI, R.,
LI, Y.,
YANG, R.,
LI, C.,
FANG, R.,
SHABANOVA, A.,
LI, X.,
LIU, Y.,
LIANG, H.,
ZHOU, Y.,
SHAN, H.,
ZHENG, N. (2020) , Met can noticeably inhibit miR-1 upregulation and attenuate the
changes mentioned above. Taken
Yunusbaeva, M.,
Borodina, L.,
Alekseev, P.,
Davydov, R.,
Sharipov, R.,
Bilalov, F.,
Yunusbayev, B. (2019) strains in the general population, which calls for urgent
changes not only in clinical practice but also
Bulgakova, NA,
Vasilyeva, NA,
Imelbaeva, EA,
Shikova, YV,
Vasiliev, EA,
Salikhova, DI (2021) the bloodstream. T-lymphocyte indices (immunoregulatory index and leuko T-cell index)
changed in different
Boykо, A.,
Fernández, O.,
Alifirova, V.,
Babicheva, N.,
Bakhtiyarova, K.,
Volkov, A.,
Glavinskaya, N.,
Goncharova, Z.,
Greshnova, I.,
Smagina, I.,
Lashch, N.,
Inzhinova, A. (2021) in
changing DMT as escalation in cases with breakthrough RRMS. The products without indication to be used